Piperlongumine reverses doxorubicin resistance through the PI3K/Akt signaling pathway in K562/A02 human leukemia cells

Drug resistance is an important obstacle to human leukemia therapeutics. Piperlongumine has previously demonstrated the ability to suppress certain human tumor processes; however, the ability of piperlongumine to reverse the drug resistance of human leukemia and its mechanism of action have not yet...

Descripción completa

Detalles Bibliográficos
Autores principales: KANG, QINGWEI, YAN, SHU
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353808/
https://www.ncbi.nlm.nih.gov/pubmed/25780433
http://dx.doi.org/10.3892/etm.2015.2254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353808/
https://www.ncbi.nlm.nih.gov/pubmed/25780433
http://dx.doi.org/10.3892/etm.2015.2254

Ejemplares similares